問卷

TPIDB > Search Result

Search Result

篩選

List

2394Cases

2020-03-13 - 2024-02-15

Phase I/II

Completed
An open phase 1b/2 trial to evaluate the pharmacokinetics, safety, efficacy and pharmacodynamics of PF-06801591 (PD-1 inhibitor) among participants in advanced malignancies
  • Condition/Disease

    NSCLC

  • Test Drug

    PF-06801591

Participate Sites
4Sites

Recruiting2Sites

Terminated2Sites

2021-08-31 - 2024-12-13

Others

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting3Sites

Terminated2Sites

2006-06-01 - 2008-12-31

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2006-06-01 - 2008-06-30

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2009-03-20 - 2010-03-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2007-11-01 - 2009-03-01

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2007-08-01 - 2008-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2011-05-01 - 2013-01-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2023-10-15 - 2025-06-18

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Not yet recruiting1Sites

Recruiting2Sites